These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8117137)

  • 1. Adverse experiences in an Exosurf treated group.
    Chatfield SL; Kelly EJ; Dear PR
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F78. PubMed ID: 8117137
    [No Abstract]   [Full Text] [Related]  

  • 2. Seizures after inadvertent umbilical venous infusion of synthetic surfactant (Exosurf): cause or coincidence?
    Frey B; Keller E; Losa M
    Eur J Pediatr; 1999 Jul; 158(7):610. PubMed ID: 10412829
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary haemorrhage in low-birthweight babies.
    Majeed-Saidan MA; al-Hifzi I; Khan M
    Lancet; 1993 Jan; 341(8837):120. PubMed ID: 8093391
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in pulmonary artery pressure in infants with respiratory distress syndrome after treatment with Exosurf.
    Rogers D
    Arch Dis Child Fetal Neonatal Ed; 1996 Mar; 74(2):F151. PubMed ID: 8777670
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute blood pressure response to surfactant administration.
    Halley GC; Stenson BJ; Laing IA; McIntosh M
    Arch Dis Child Fetal Neonatal Ed; 1995 Nov; 73(3):F197. PubMed ID: 8535884
    [No Abstract]   [Full Text] [Related]  

  • 6. Surfactant therapy for hyaline membrane disease: the Chandigarh experience.
    Narang A; Kumar P; Dutta S; Kumar R
    Indian Pediatr; 2001 Jun; 38(6):640-6. PubMed ID: 11418729
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary haemorrhage, surfactant, and low-birthweight babies.
    Rogers D
    Lancet; 1993 Mar; 341(8846):698. PubMed ID: 8095608
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
    Speer CP; Robertson B; Halliday HL
    Acta Paediatr; 2000 May; 89(5):510-2. PubMed ID: 10852182
    [No Abstract]   [Full Text] [Related]  

  • 9. Retrospective search for bleeding diathesis among premature newborn infants with pulmonary hemorrhage after synthetic surfactant treatment. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Allen A; McMillan D; Boros S; Vaughan R; Gerdes J; Houle L; Edwards K; Schiff D
    J Pediatr; 1992 Feb; 120(2 Pt 2):S45-8. PubMed ID: 1735852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    van Houten J; Long W; Mullett M; Finer N; Derleth D; McMurray B; Peliowski A; Walker D; Wold D; Sankaran K
    J Pediatr; 1992 Feb; 120(2 Pt 2):S40-4. PubMed ID: 1735851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Sangstad OD
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
    [No Abstract]   [Full Text] [Related]  

  • 12. Surfactant replacement therapy in neonates less than 32 weeks gestation: effect on neonatal intensive care resource utilization.
    Diwaker K; Roberts S; John E
    J Paediatr Child Health; 1993 Dec; 29(6):434-7. PubMed ID: 8286159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surfactant therapy in newborns with hyaline membrane disease].
    Tsvetkova S; Chernookova V; Efremova R; Nedeva N; Bogdanova V
    Akush Ginekol (Sofiia); 2000; 39 Suppl 2():12-4. PubMed ID: 11188005
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
    Kukkonen AK; Virtanen M; Järvenpää AL; Pokela ML; Ikonen S; Fellman V
    Acta Paediatr; 2000 May; 89(5):556-61. PubMed ID: 10852192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
    Phibbs RH; Ballard RA; Clements JA; Heilbron DC; Phibbs CS; Schlueter MA; Sniderman SH; Tooley WH; Wakeley A
    Pediatrics; 1991 Jul; 88(1):1-9. PubMed ID: 2057244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous surfactant decreases oxygenation in Escherichia coli endotoxin-treated neonatal piglets.
    Sood SL; Balaraman V; Finn KC; Wilkerson SY; Mundie TG; Easa D
    Pediatr Pulmonol; 1996 Dec; 22(6):376-86. PubMed ID: 9016471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
    Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia.
    Husain AN; Siddiqui NH; Stocker JT
    Hum Pathol; 1998 Jul; 29(7):710-7. PubMed ID: 9670828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exosurf-Neonatal: the synthetic surfactant. Introductory symposium, 20 June 1992].
    Monatsschr Kinderheilkd; 1992 Sep; 140(9 [EXOSURF]):1-12. PubMed ID: 1406736
    [No Abstract]   [Full Text] [Related]  

  • 20. Criteria for use of colfosceril (Exosurf) in neonates.
    Bhatt-Mehta V; Schumacher RE
    Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.